Insider Transactions in Q2 2022 at Prestige Consumer Healthcare Inc. (PBH)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 13
2022
|
Adel Mekhail EVP, Marketing & Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
2,868
-17.73%
|
$160,608
$56.78 P/Share
|
May 06
2022
|
Ronald M. Lombardi Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
56,233
-10.28%
|
$3,036,582
$54.88 P/Share
|
May 06
2022
|
Ronald M. Lombardi Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
107,916
+27.96%
|
-
|
May 06
2022
|
William P'Pool Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,553
-9.37%
|
$245,862
$54.88 P/Share
|
May 06
2022
|
William P'Pool Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,331
+22.61%
|
-
|
May 06
2022
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
2,461
-7.69%
|
$132,894
$54.88 P/Share
|
May 06
2022
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
4,132
+20.11%
|
-
|
May 06
2022
|
Christine Sacco CFO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,300
-8.47%
|
$394,200
$54.88 P/Share
|
May 06
2022
|
Christine Sacco CFO & COO |
BUY
Grant, award, or other acquisition
|
Direct |
12,243
+21.63%
|
-
|
May 06
2022
|
Jeffrey Zerillo Senior VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,975
-4.01%
|
$160,650
$54.88 P/Share
|
May 06
2022
|
Jeffrey Zerillo Senior VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,990
+9.5%
|
-
|
May 04
2022
|
Jeffrey Zerillo Senior VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
423
-1.28%
|
$23,265
$55.34 P/Share
|
May 04
2022
|
Adel Mekhail EVP, Marketing & Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
482
-2.89%
|
$26,510
$55.34 P/Share
|
May 04
2022
|
William P'Pool Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
658
-3.57%
|
$36,190
$55.34 P/Share
|
May 04
2022
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
355
-2.81%
|
$19,525
$55.34 P/Share
|
May 04
2022
|
Christine Sacco CFO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,055
-3.18%
|
$58,025
$55.34 P/Share
|
May 04
2022
|
Ronald M. Lombardi Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,099
-1.79%
|
$170,445
$55.34 P/Share
|
May 03
2022
|
Jeffrey Zerillo Senior VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
446
-1.33%
|
$24,084
$54.44 P/Share
|
May 03
2022
|
Adel Mekhail EVP, Marketing & Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-2.7%
|
$24,948
$54.44 P/Share
|
May 03
2022
|
William P'Pool Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
623
-3.27%
|
$33,642
$54.44 P/Share
|
May 03
2022
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
404
-3.1%
|
$21,816
$54.44 P/Share
|
May 03
2022
|
Christine Sacco CFO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,150
-3.35%
|
$62,100
$54.44 P/Share
|
May 03
2022
|
Ronald M. Lombardi Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,000
-1.7%
|
$162,000
$54.44 P/Share
|
May 02
2022
|
Jeffrey Zerillo Senior VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,142
+6.02%
|
-
|
May 02
2022
|
Adel Mekhail EVP, Marketing & Sales |
BUY
Grant, award, or other acquisition
|
Direct |
3,060
+15.17%
|
-
|
May 02
2022
|
William P'Pool Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,182
+14.32%
|
-
|
May 02
2022
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
1,989
+13.23%
|
-
|
May 02
2022
|
Christine Sacco CFO & COO |
BUY
Grant, award, or other acquisition
|
Direct |
6,120
+15.14%
|
-
|
May 02
2022
|
Ronald M. Lombardi Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,523
+8.57%
|
-
|